Observed differences in invasive pneumococcal disease epidemiology after routine infant vaccination (Q37844538)

24 August 2017

1 reference

title

Observed differences in invasive pneumococcal disease epidemiology after routine infant vaccination (English)

1 reference

24 August 2017

1 reference

3

Maarten J Postma

1 reference

24 August 2017

Mark H Rozenbaum

1

1 reference

24 August 2017

Cornelis Boersma

series ordinal

2

1 reference

24 August 2017

Eelko Hak

series ordinal

4

1 reference

24 August 2017

1 February 2011

1 reference

Expert Review of Vaccines

24 August 2017

1 reference

24 August 2017

10

1 reference

24 August 2017

2

1 reference

24 August 2017

187-199

1 reference

Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines

24 August 2017

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Huge impact of assumptions on indirect effects on the cost-effectiveness of routine infant vaccination with 7-valent conjugate vaccine (Prevnar).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Decline in pneumococcal meningitis after the introduction of the heptavalent-pneumococcal conjugate vaccine in northern France

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Pneumococcal bacteremia among infants with fever without known source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Changes in serotypes causing invasive pneumococcal disease (2005-2007 vs. 1997-1999) in children under 2 years of age in a population with intermediate coverage of the 7-valent pneumococcal conjugated vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

National paediatric immunization program of high risk groups: no effect on the incidence of invasive pneumococcal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Streptococcus pneumoniae serotype 19A in children, South Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Temporal and spatial distribution of clonal complexes of Streptococcus pneumoniae isolates resistant to multiple classes of antibiotics in Belgium, 1997 to 2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Rethinking replacement and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Dynamics of penicillin-susceptible clones in invasive pneumococcal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Denmark14-230 clone as an increasing cause of pneumococcal infection in Portugal within a background of diverse serotype 19A lineages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Emergence of Streptococcus pneumoniae of serotype 19A in France: molecular capsular serotyping, antimicrobial susceptibilities, and epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Vaccine escape recombinants emerge after pneumococcal vaccination in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Pneumococcal capsular polysaccharide structure predicts serotype prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Association of serotype of Streptococcus pneumoniae with risk of severe and fatal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Serious and invasive pediatric pneumococcal disease: epidemiology and vaccine impact in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Reduced physician claims for otitis media after implementation of pneumococcal conjugate vaccine program in the province of Quebec, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Invasive pneumococcal disease in the Netherlands: Syndromes, outcome and potential vaccine benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

The Immunogenicity of 7‐Valent Pneumococcal Conjugate Vaccine versus 23‐Valent Polysaccharide Vaccine in Adults Aged 50–80 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Changing Epidemiology of Invasive Pneumococcal Disease in Canada, 1998–2007: Update from the Calgary‐Area Streptococcus pneumoniae Research (CASPER) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000–2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Clonal and Capsular Types Decide Whether Pneumococci Will Act as a Primary or Opportunistic Pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Effect of Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization among Immunized and Unimmunized Children in a Community‐Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Invasive Pneumococcal Disease a Decade after Pneumococcal Conjugate Vaccine Use in an American Indian Population at High Risk for Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996–2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged ≥65 years in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.163

21 January 2018

Identifiers

DOI

10.1586/ERV.10.163

1 reference

release_t4mbgluzyzcnno4h5ydxkqb3wu

24 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/t4mbgluzyzcnno4h5ydxkqb3wu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference